Cannabinoid type 1 receptor inverse agonism attenuates dyslipidemia and atherosclerosis in APOE*3-Leiden.CETP mice

van Eenige, R; Ying, ZX; Tambyrajah, L; Pronk, ACM; Blomberg, N; Giera, M; Wang, YA; Coskun, T; van der Stelt, M; Rensen, PCN; Kooijman, S

Rensen, PCN (corresponding author), Leiden Univ, Med Ctr, Dept Med, Div Endocrinol, Leiden, Netherlands.; Rensen, PCN (corresponding author), Leiden Univ, Med Ctr, Einthoven Lab Expt Vasc Med, Leiden, Netherlands.; Rensen, PCN (corresponding author), Xi An Jiao Tong Univ, Affiliated Hosp 1, Ctr Immunol & Metab Dis, Med X Inst, Xian, Peoples R China.; Rensen, PCN (corresponding author), Xi An Jiao Tong Univ, Affiliated Hosp 1, Dept Endocrinol, Xian, Peoples R China.

JOURNAL OF LIPID RESEARCH, 2021; 62 ():

Abstract

Pharmacological blockade of the cannabinoid type 1 receptor, a G protein-coupled receptor expressed in the central nervous system and various peripher......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索